Effect of Cilostazol on Patients With Diabetes Who Underwent Endovascular Treatment for Peripheral Artery Disease

BACKGROUND: No large‐scale study has compared the clinical impact of triple antiplatelet therapy (TAPT: aspirin, clopidogrel, and cilostazol) and dual antiplatelet therapy (DAPT) on adverse limb events in patients with diabetes after endovascular therapy (EVT) for peripheral artery disease. Thus, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Cha, Jung‐Joon, Cho, Jae Young, Lim, Subin, Kim, Ju Hyeon, Joo, Hyung Joon, Park, Jae Hyoung, Hong, Soon Jun, Lim, Do‐Sun, Kook, Hyungdon, Lee, Seung Hun, Ko, Young‐Guk, Min, Pil‐Ki, Lee, Jae‐Hwan, Yoon, Chang‐Hwan, Chae, In‐Ho, Lee, Seung Whan, Lee, Sang‐Rok, Choi, Seung Hyuk, Koh, Yoon Seok, Yu, Cheol Woong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356016/
https://www.ncbi.nlm.nih.gov/pubmed/37301738
http://dx.doi.org/10.1161/JAHA.122.027334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356016/
https://www.ncbi.nlm.nih.gov/pubmed/37301738
http://dx.doi.org/10.1161/JAHA.122.027334

Ejemplares similares